pubmed:abstractText |
The mammalian target of rapamycin (mTOR), which phosphorylates p70S6K and 4EBP1 and activates the protein translation process, is upregulated in cancers and its activation may be involved in cancer development. Aims: In this study, we investigated the tumour-suppressive effects of rapamycin and its new analogue CCI-779 on hepatocellular carcinoma (HCC).
|
pubmed:affiliation |
Liver Cancer and Hepatitis Research Laboratory, Department of Pathology, LKS Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong, China.
|